EAM
BSX icon

Exome Asset Management’s Boston Scientific BSX Stock Holding History

Exome Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Hold
48,347
– – 1.27% 28
2026
Q1 		$3.03M Buy
+48,347
New +$3.87M 1.57% 24
2025
Q1 		– Sell
-40,500
Closed -$3.62M – 66
2024
Q4 		$3.62M Buy
+40,500
New +$3.57M 2.72% 14

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Exome Asset Management's BSX Position: Q2 2026 in Review

Exome Asset Management held its Boston Scientific (BSX) position steady in Q2 2026 at 48,347 shares worth $2.06M. The position accounts for 1.27% of the portfolio, ranked #28.

Exome Asset Management first reported a position in BSX in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.62M in Q4 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Exome Asset Management held 48,347 shares of Boston Scientific worth $2.06M as of Q2 2026.
  • Exome Asset Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 1.27% of Exome Asset Management's portfolio in Q2 2026, its #28 holding.
  • Exome Asset Management first reported a position in Boston Scientific in Q4 2024 and has held it in 3 quarters since.
  • Exome Asset Management's Boston Scientific position peaked at $3.62M in Q4 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.